Key result
Hypertension chronotherapy faces ongoing advances and controversies across the latest ESC, Chinese, and AHA/ACC guidelines.
Population
Adults with hypertension
Design
Review
Authors
Loading...
Expert review underscores persistent guideline inconsistencies on chronotherapy in hypertension; leaves open the need for definitive trials before practice change.
This paper reviews recent advances and controversies regarding chronotherapy in the management of adult hypertension across major international guidelines.
Lee et al. (2026) studied this question. Chronotherapy for adult hypertension involves ongoing advances and controversies across the 2024 ESC, 2024 Chinese, and 2025 AHA/ACC guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: